BNP Paribas Financial Markets
MREO

BNP Paribas Financial Markets’s Mereo BioPharma MREO Stock Holding History

BNP Paribas Financial Markets’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Hold
3
– – ﹤0.01% 5896
2026
Q1 		$1 Hold
3
– – ﹤0.01% 5800
2025
Q4 		$1 Hold
3
– – ﹤0.01% 5726
2025
Q3 		$6 Hold
3
– – ﹤0.01% 5533
2025
Q2 		$8 Hold
3
– – ﹤0.01% 5412
2025
Q1 		$7 Hold
3
– – ﹤0.01% 5348
2024
Q4 		$10 Sell
3
-1,400
-100% -$5.5K ﹤0.01% 5360
2024
Q3 		$5.77K Sell
1,403
-19,132
-93% -$79.1K ﹤0.01% 3834
2024
Q2 		$73.9K Buy
20,535
+3,100
+18% +$10K ﹤0.01% 3364
2024
Q1 		$57.5K Buy
17,435
+17,432
+581,067% +$59K ﹤0.01% 3556
2023
Q4 		$7 Hold
3
– – ﹤0.01% 3986
2023
Q3 		$4 Hold
3
– – ﹤0.01% 3900
2023
Q2 		$4 Sell
3
-558
-99% -$647 ﹤0.01% 3905
2023
Q1 		$397 Hold
561
– – ﹤0.01% 3728
2022
Q4 		$421 Buy
561
+24
+4% +$20 ﹤0.01% 3880
2022
Q3 		$462 Sell
537
-2,892
-84% -$3.54K ﹤0.01% 4527
2022
Q2 		$3.84K Buy
+3,429
New +$2.66K ﹤0.01% 3844

Other funds holding MREO

TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JJBC
James J. Burns & Company Melville, New York $924M AUM 22.18% 1-Year Est. Return
JF
JMN Financial New Albany, Ohio $129M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

BNP Paribas Financial Markets's MREO Position: Q2 2026 in Review

BNP Paribas Financial Markets held its Mereo BioPharma (MREO) position steady in Q2 2026 at 3 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #5896.

BNP Paribas Financial Markets first reported a position in MREO in Q2 2022 and has held it in 17 quarters since. The position peaked at $73.9K in Q2 2024. 38 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

  • BNP Paribas Financial Markets held 3 shares of Mereo BioPharma worth $1 as of Q2 2026.
  • BNP Paribas Financial Markets left its Mereo BioPharma share count unchanged in Q2 2026.
  • Mereo BioPharma made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5896 holding.
  • BNP Paribas Financial Markets first reported a position in Mereo BioPharma in Q2 2022 and has held it in 17 quarters since.
  • BNP Paribas Financial Markets's Mereo BioPharma position peaked at $73.9K in Q2 2024.
  • 38 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.